REYON Pharmaceutical Co., Ltd. (KRX: 102460)

REYON Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6,418	24,107	16,049	66,741	12,196	5,825
Short-Term Investments	-	-	20,000	30,380	32,900	53,500
Trading Asset Securities	6.05	134.02	19.83	327.64	371.8	0.97
Cash & Short-Term Investments	6,424	24,241	36,069	97,448	45,468	59,326
Cash Growth	-78.68%	-32.79%	-62.99%	114.32%	-23.36%	-60.76%
Accounts Receivable	37,645	39,927	41,810	40,465	39,946	44,476
Other Receivables	124.57	50.98	238.02	384.38	3,768	2,299
Receivables	37,770	39,978	42,048	40,850	43,714	46,774
Inventory	37,206	35,176	30,109	26,432	28,438	24,006
Prepaid Expenses	40.69	229.57	28.53	32.51	33.16	29.87
Other Current Assets	517.03	188.61	751.89	41.89	120.34	172.16
Total Current Assets	81,957	99,813	109,006	164,804	117,774	130,309
Property, Plant & Equipment	383,544	368,342	340,568	281,156	170,971	113,834
Long-Term Investments	19,465	21,216	26,211	24,557	21,150	20,812
Other Intangible Assets	856.44	1,392	1,404	1,427	1,442	1,893
Long-Term Deferred Tax Assets	5,125	5,075	4,104	2,004	2,058	1,919
Long-Term Deferred Charges	2,800	2,800	2,800	2,800	2,800	2,800
Other Long-Term Assets	1,112	1,137	598.41	1,230	1,415	1,920
Total Assets	494,860	499,776	484,692	477,978	317,610	273,487
Accounts Payable	7,353	8,186	4,793	4,731	4,168	4,119
Accrued Expenses	3,646	3,776	3,646	2,253	1,793	1,309
Short-Term Debt	27,280	100,656	22,500	22,500	20,420	12,000
Current Portion of Leases	1,521	1,610	2,254	1,911	2,571	2,499
Current Income Taxes Payable	553	852.4	733.48	426.48	297.61	437.67
Other Current Liabilities	82,375	10,522	14,025	15,682	19,504	12,670
Total Current Liabilities	130,728	125,602	47,951	47,503	48,754	33,035
Long-Term Debt	115,000	121,000	184,218	182,425	33,800	14,603
Long-Term Leases	677.56	1,788	1,231	478.19	2,644	4,553
Long-Term Deferred Tax Liabilities	127.57	12.95	-	7.09	-	-
Other Long-Term Liabilities	926.92	2,748	3,526	2,328	2,323	-0
Total Liabilities	247,460	251,151	236,926	232,741	87,521	52,191
Common Stock	9,293	9,293	8,999	8,999	8,781	8,385
Additional Paid-In Capital	38,955	38,955	39,003	39,003	26,281	13,826
Retained Earnings	204,851	205,997	205,151	202,281	200,208	203,004
Treasury Stock	-5,079	-5,079	-5,079	-5,079	-5,002	-5,002
Comprehensive Income & Other	-620.35	-541.75	-559.4	-217.03	-178.11	-1,007
Total Common Equity	247,400	248,625	247,515	244,987	230,089	219,205
Minority Interest	-	-	-	-	-	2,091
Shareholders' Equity	247,400	248,625	247,765	245,237	230,089	221,296
Total Liabilities & Equity	494,860	499,776	484,692	477,978	317,610	273,487
Total Debt	152,479	225,054	210,203	207,314	59,435	33,655
Net Cash (Debt)	-146,055	-200,813	-174,134	-109,866	-13,967	25,671
Net Cash Growth	-	-	-	-	-	-77.85%
Net Cash Per Share	-7963.29	-10948.85	-9538.14	-6200.33	-820.17	1522.72
Filing Date Shares Outstanding	18.34	18.34	17.75	17.75	17.32	16.86
Total Common Shares Outstanding	18.34	18.34	18.25	17.75	17.67	16.86
Working Capital	-48,771	-25,789	61,055	117,301	69,020	97,274
Book Value Per Share	13488.91	13555.68	13560.43	13799.95	13023.92	13002.70
Tangible Book Value	246,544	247,233	246,111	243,561	228,647	217,312
Tangible Book Value Per Share	13442.21	13479.79	13483.51	13719.59	12942.27	12890.41
Land	12,362	12,362	12,362	12,362	12,362	12,362
Buildings	12,712	12,712	12,712	12,712	12,712	9,540
Machinery	44,419	43,939	42,519	39,530	38,263	36,695
Construction In Progress	359,796	342,022	314,018	256,737	142,914	87,358

Source: S&P Capital IQ. Standard template. Financial Sources.